Bandaram Pharma Packtech Reports Decline in Financial Performance for Q1 FY25
Bandaram Pharma Packtech, a microcap company in the medical equipment industry, recently announced its financial results for the quarter ending June 2024. The company’s stock has been given a ‘Sell’ call by MarketsMOJO.
According to the financial report, Bandaram Pharma’s performance for the quarter has been flat, with a score of -5 compared to 0 in the previous quarter. This indicates a decline in the company’s financial health in the last three months.
One of the major factors contributing to this decline is the net sales, which have decreased by 24.16% year on year, standing at Rs 9.92 crore. The near-term sales trend for the company is also negative.
In terms of operating profit, Bandaram Pharma has recorded its lowest figure in the last five quarters, at Rs -0.25 crore. This indicates a negative trend in the near term for the company’s operating profit.
Similarly, the profit before tax (PBT) has also decreased to its lowest figure in the last five quarters, standing at Rs -0.25 crore. This trend is also expected to continue in the near term.
The company’s earnings per share (EPS) have also declined, with the lowest figure of Rs -0.21 in the last five quarters. This indicates a decline in profitability and lower earnings for shareholders.
Overall, the financial results for the quarter ending June 2024 have not been favorable for Bandaram Pharma Packtech. Investors are advised to take note of the negative trends and make informed decisions regarding their investments in the company’s stock.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
